Moroni, Gabriella Luisa
 Distribuzione geografica
Continente #
AS - Asia 3.814
NA - Nord America 2.972
SA - Sud America 905
EU - Europa 507
AF - Africa 82
OC - Oceania 7
Totale 8.287
Nazione #
US - Stati Uniti d'America 2.809
SG - Singapore 2.260
BR - Brasile 740
CN - Cina 559
VN - Vietnam 460
HK - Hong Kong 184
IT - Italia 160
AR - Argentina 70
MX - Messico 69
CA - Canada 59
GB - Regno Unito 59
IN - India 56
ID - Indonesia 43
BD - Bangladesh 40
DE - Germania 40
EC - Ecuador 34
FR - Francia 29
PL - Polonia 27
FI - Finlandia 26
IE - Irlanda 25
PK - Pakistan 23
IQ - Iraq 22
TR - Turchia 21
UA - Ucraina 21
JP - Giappone 20
ZA - Sudafrica 19
AT - Austria 17
CO - Colombia 17
MY - Malesia 17
PH - Filippine 17
ES - Italia 16
MA - Marocco 16
NL - Olanda 16
RU - Federazione Russa 14
CL - Cile 13
SE - Svezia 13
AE - Emirati Arabi Uniti 12
SA - Arabia Saudita 11
VE - Venezuela 11
EG - Egitto 10
TN - Tunisia 10
PY - Paraguay 9
AL - Albania 8
AZ - Azerbaigian 8
CR - Costa Rica 8
JO - Giordania 7
KE - Kenya 7
CH - Svizzera 6
PA - Panama 6
UZ - Uzbekistan 6
BG - Bulgaria 5
TH - Thailandia 5
UY - Uruguay 5
ET - Etiopia 4
KZ - Kazakistan 4
LA - Repubblica Popolare Democratica del Laos 4
NP - Nepal 4
NZ - Nuova Zelanda 4
OM - Oman 4
SV - El Salvador 4
BB - Barbados 3
BH - Bahrain 3
DO - Repubblica Dominicana 3
IL - Israele 3
JM - Giamaica 3
KG - Kirghizistan 3
LT - Lituania 3
NG - Nigeria 3
PE - Perù 3
BA - Bosnia-Erzegovina 2
BE - Belgio 2
BY - Bielorussia 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
GR - Grecia 2
GY - Guiana 2
HU - Ungheria 2
KH - Cambogia 2
KR - Corea 2
LB - Libano 2
LK - Sri Lanka 2
MD - Moldavia 2
MU - Mauritius 2
NI - Nicaragua 2
QA - Qatar 2
RS - Serbia 2
SN - Senegal 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AG - Antigua e Barbuda 1
AM - Armenia 1
AO - Angola 1
AU - Australia 1
BO - Bolivia 1
BW - Botswana 1
CG - Congo 1
CI - Costa d'Avorio 1
GD - Grenada 1
GI - Gibilterra 1
GT - Guatemala 1
Totale 8.271
Città #
Singapore 973
San Jose 547
Ashburn 546
The Dalles 443
Hong Kong 182
Beijing 178
Dallas 162
Ho Chi Minh City 159
Shanghai 134
Hanoi 112
New York 97
Santa Clara 74
São Paulo 62
Los Angeles 55
Mexico City 45
Boardman 43
Buffalo 40
Wilmington 31
Naples 29
Assago 28
Warsaw 27
Helsinki 26
Dublin 23
Haiphong 21
Brooklyn 20
Chandler 20
Rio de Janeiro 20
Da Nang 19
Montreal 19
Tokyo 19
Orem 17
Rome 16
Milan 15
Belo Horizonte 14
Boston 14
Fort Worth 14
Brasília 13
Curitiba 13
Hải Dương 13
Phoenix 13
Seattle 13
Biên Hòa 12
Chicago 12
Council Bluffs 12
Jakarta 12
Johannesburg 12
Quito 12
Stockholm 11
Vienna 11
Campinas 10
Chennai 10
Prineville 10
Salvador 10
San Mateo 10
Can Tho 9
Hillsboro 9
Kuala Lumpur 9
San Francisco 9
Springfield 9
Atlanta 8
Baghdad 8
Baku 8
Buenos Aires 8
Guayaquil 8
Mumbai 8
Nuremberg 8
Poplar 8
Reston 8
Thái Bình 8
Amman 7
Amsterdam 7
Charlotte 7
Denver 7
Dhaka 7
Porto Alegre 7
Ankara 6
Asunción 6
Bắc Ninh 6
Dubai 6
Frankfurt am Main 6
London 6
Manchester 6
Nairobi 6
San José 6
Santiago 6
Sorocaba 6
Toronto 6
Wuhan 6
Campos dos Goytacazes 5
Canoas 5
Castro dei Volsci 5
Hyderabad 5
Istanbul 5
Karachi 5
Kyiv 5
Lahore 5
Manaus 5
Manila 5
Montevideo 5
Nova Friburgo 5
Totale 4.758
Nome #
Clinical-Pathological Characteristics of Renal Injuries Identify Different Clusters in Patients With Antiphospholipid Antibodies 131
Acute tubular necrosis following interferon-based therapy for hepatitis C : case study with literature review 123
De novo membrano-proliferative nephritis following interferon therapy for chronic hepatitis c (case study and literature review) 85
Herpes zoster in lupus nephritis: experience on 292 patients followed up for 15 years 84
2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis 79
A best practice position statement on pregnancy in chronic kidney disease: the Italian Study Group on Kidney and Pregnancy 77
Kidney Biopsy in Pregnant Women with Glomerular Diseases: Focus on Lupus Nephritis 74
Changing Phenotypes and Clinical Outcomes Over Time in Microscopic Polyangiitis 71
Long-term kidney outcome of patients with rheumatological diseases and antineutrophil cytoplasmic antibody-glomerulonephritis: comparison with a primitive ANCA-glomerulonephritis cohort 70
Beyond ISN/RPS Lupus Nephritis Classification: Adding Chronicity Index to Clinical Variables Predicts Kidney Survival 70
Clinical and histological findings at second but not at first kidney biopsy predict end-stage kidney disease in a large multicentric cohort of patients with active lupus nephritis 69
Nephrotic syndrome: pathophysiology and consequences 68
Is per-protocol kidney biopsy required in lupus nephritis? 67
Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: a clinical observational study 67
ANCA-associated vasculitis with renal involvement 64
A best-practice position statement on pregnancy after kidney transplantation: focusing on the unsolved questions. The Kidney and Pregnancy Study Group of the Italian Society of Nephrology 64
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update 63
Cardiovascular Risk after Kidney Transplantation: Causes and Current Approaches to a Relevant Burden 60
Autosomal Dominant Polycystic Kidney Disease: Is There a Role for Autophagy? 60
Effect of Sustained Clinical Remission on the Risk of Lupus Flares and Impaired Kidney Function in Patients With Lupus Nephritis 60
Comparison of EULAR/PRINTO/PReS Ankara 2008 and 2022 ACR/EULAR Classification Criteria for Granulomatosis with Polyangiitis in Children 60
''Nephritic flares'' are predictors of bad long-term renal outcome in lupus nephritis 59
A best practice position statement on pregnancy in chronic kidney disease: the Italian Study Group on Kidney and Pregnancy (vol 29, pg 277, 2016) 59
Immunosuppressive and antiviral treatment of hepatitis C virus-associated glomerular disease: A long-term follow-up 59
2019 update of the EULAR recommendations for the management of systemic lupus erythematosus 58
Prevalence and clinical significance of ANCA positivity in lupus nephritis: a case series of 116 patients and literature review 58
Anti-C1q antibodies: a biomarker for diagnosis and management of lupus nephritis. A narrative review 57
Monoclonal gammopathy in lupus nephritis 55
Contraception in chronic kidney disease: a best practice position statement by the Kidney and Pregnancy Group of the Italian Society of Nephrology 55
The value of the current histological scores and classifications of ANCA glomerulonephritis in predicting long-term outcome 55
Anti-neutrophil cytoplasmic antibody-associated vasculitis in kidney transplantation 54
Neutrophil Extracellular Traps in the Autoimmunity Context 53
Delayed Graft Function in Kidney Transplant: Risk Factors, Consequences and Prevention Strategies 53
Prognostic factors and long-term outcome with anca-associated kidney vasculitis in childhood 52
History of Preeclampsia in Patients Undergoing a Kidney Biopsy: A Biphasic, Multiple-Hit Pathogenic Hypothesis 52
Anti-glomerular basement membrane vasculitis 51
Acid-base balance and respiratory response during biofiltration with polyacrylonitrile membrane 51
Slowly progressive anti-neutrophil cytoplasmic antibody-associated renal vasculitis: Clinico-pathological characterization and outcome 50
A critical view on autoantibodies in lupus nephritis: Concrete knowledge based on evidence 50
Anti-C1Q monitoring predicts relapses of lupus nephritis 50
Anti-C1q antibodies may help in diagnosing a renal flare in lupus nephritis 49
Predictors of increase in chronicity index and of kidney function impairment at repeat biopsy in lupus nephritis 49
Acute post-bacterial glomerulonephritis in renal transplant patients: Description of three cases and review of the literature 49
Long-term outcome of renal transplantation in adults with focal segmental glomerulosclerosis 49
Renal replacement therapy in sarcoidosis 49
Abnormalities of homocysteine and B vitamins in the nephrotic syndrome 49
C3 glomerulopathies: dense deposit disease and C3 glomerulonephritis 49
Hyperuricemia as a trigger of immune response in hypertension and chronic kidney disease 48
A best practice position statement on the role of the nephrologist in the prevention and follow-up of preeclampsia: the Italian study group on kidney and pregnancy 48
Sirolimus plus prednisone for Erdheim-Chester disease: an open-label trial 47
Lupus Membranous Nephropathy 47
Anti-C1q Autoantibodies in Lupus Nephritis 47
Autophagy: A Silent Protagonist in Kidney Transplantation 46
A large-scale genetic analysis reveals an autoimmune origin of idiopathic retroperitoneal fibrosis 45
A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years 45
Lack of EULAR/ERA-EDTA response at 1 year predicts poor long-term renal outcome in patients with lupus nephritis 45
Lupus nephritis: When and how often to biopsy and what does it mean? 45
Acute renal failure in a single kidney with previous obstruction 44
Long-term prognosis of diffuse proliferative glomerulonephritis associated with infection in adults 44
Glomerular diseases in pregnancy: pragmatic recommendations for clinical management 44
Predictors of renal survival in ANCA-associated vasculitis. Validation of a histopathological classification schema and review of the literature 44
Idiopathic retroperitoneal fibrosis: Clinicopathologic features and differential diagnosis 44
Lupus nephritis: clinical presentations and outcomes in the 21st century 44
Rituximab monotherapy for remission induction of proliferative lupus nephritis flares: description of 3 cases 43
Coexistence of Different Circulating Anti-Podocyte Antibodies in Membranous Nephropathy 43
Alport syndrome and pregnancy: a case series and literature review 43
Old and new calcineurin inhibitors in lupus nephritis 43
Neutrophil Extracellular Traps Profiles in Patients with Incident Systemic Lupus Erythematosus and Lupus Nephritis 42
Complement levels during the first trimester predict disease flare and adverse pregnancy outcomes in systemic lupus erythematosus: A network meta-analysis on 532 pregnancies 42
Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases 42
Thin Basement Membrane: An Underrated Cause of End-Stage Renal Disease 42
Glomerular autoimmune multicomponents of human lupus nephritis in vivo (2): Planted antigens 41
Multicentric study comparing cyclosporine, mycophenolate mofetil and azathioprine in the maintenance therapy of lupus nephritis: 8 years follow up 41
How We Treat Dyslipidemia in Prolonged Nephrotic Syndrome 41
Is preeclampsia a risk for end-stage renal disease? 41
Rituximab therapy for primary glomerulonephritis: Report on two cases 41
Changing patterns in clinical-histological presentation and renal outcome over the last five decades in a cohort of 499 patients with lupus nephritis 41
Chronic kidney disease, female infertility, and medically assisted reproduction: a best practice position statement by the Kidney and Pregnancy Group of the Italian Society of Nephrology 40
When and How Is It Possible to Stop Therapy in Patients with Lupus Nephritis: A Narrative Review 40
Pregnancy in lupus nephritis 39
Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis 39
Progressive improvement of patient and renal survival and reduction of morbidity over time in patients with lupus nephritis (LN) followed for 20 years 39
Treatment of membranous lupus nephritis 39
Does pregnancy have any impact on long term damage accrual and on the outcome of lupus nephritis? 39
Risk of acute arterial and venous thromboembolic events in eosinophilic granulomatosis with polyangiitis (Churg–Strauss syndrome) 39
Clinical and peculiar immunological manifestations of SARS-CoV-2 infection in systemic lupus erythematosus patients 39
Hydroxychloroquine in systemic lupus erythematosus (SLE) 38
Are IF-ANA the guiding light for SLE classification in the real-world setting? 38
Neuropsychiatric Outcome of Children Born to Women With Systemic Lupus Erythematosus and Exposed in Utero to Azathioprine: A Case-Control Study 38
Renal disorders in rheumatologic diseases: the spectrum is changing (part 2. Arthridides) 38
Belimumab may decrease flare rate and allow glucocorticoid withdrawal in lupus nephritis (including dialysis and transplanted patient) 38
Remission in systemic lupus erythematosus: testing different definitions in a large multicentre cohort 38
Anti-DNA antibodies: a diagnostic and prognostic tool for systemic lupus erythematosus? 38
Withdrawal of therapy in patients with proliferative lupus nephritis: long-term follow-up 38
Treatment of dyslipidemia in kidney transplantation 38
Laser capture microdissection on formalin-fixed and paraffin-embedded renal transplanted biopsies: Technical perspectives for clinical practice application 37
The Impact of Preeclampsia in Lupus Nephritis 37
Renal replacement therapy in cryoglobulinaemic nephritis 37
The Impact of Anti-SARS-CoV-2 Vaccine in Patients with Systemic Lupus Erythematosus: A Multicentre Cohort Study 37
Renal disorders in rheumatologic diseases: the spectrum is changing (Part 1: connective tissue diseases) 37
Totale 5.133
Categoria #
all - tutte 43.706
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.706


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20216 0 0 0 0 0 0 0 0 0 0 0 6
2021/202220 1 0 0 4 2 2 1 3 0 2 4 1
2022/202370 7 2 5 7 4 4 2 4 6 5 4 20
2023/2024267 33 12 47 20 14 41 33 10 4 2 17 34
2024/20252.195 12 97 65 14 17 232 135 172 265 595 292 299
2025/20265.939 813 388 322 667 223 348 1.411 384 378 493 281 231
Totale 8.531